Ulcerative Colitis

Gastroenterologists (doctors with specialized training in treating disorders of the bowel and other digestive organs) may be consulted to help diagnose and treat IBS.

The February 22, 2006, issue of JAMA includes an article about irritable bowel syndrome.

This Patient Page is based on one previously published in the August 18, 2004, issue of JAMA.

SIGNS AND SYMPTOMS OF IBS Bloating and gas (particularly after eating) Abdominal cramping Constipation Diarrhea Urgency to have a bowel movement, sometimes right after having one Abnormal stool form (including the passage of mucus) Medical testing may be done to rule out other causes of these symptoms.

Blood in the stool is an important reason to see your doctor.

It is not a typical symptom of IBS.

WHAT MAKES IBS WORSE?

Stress Eating a large meal High-fat meals Menstrual periods If your symptoms become worse after drinking milk or eating other dairy products, you may have lactose intolerance.

This intolerance is the inability to digest the sugars (lactose) found in milk and is not part of IBS.

Foods themselves do not cause IBS.

However, persons with IBS may find that certain foods make their symptoms worse.

TREATMENT Reduce stress.

Eat a healthful, balanced diet and avoid foods that trigger an increase in your symptoms.

Small meals during the day (instead of 3 large meals) may be bene...

Nagi, Head of the Department of Gastroenterology, said said Crohn’s Disease is a great diagnostic dilemma and closely mimics gastrointestinal tuberculosis.

He said radiology may help in differentiating the two disorders.

Your comment[s] on this article Be the first to comment on this story.

Write to the Editor Mail this Story Print this Story Search News Advanced Search » Page One Site Map © 2005: Indian Express Newspapers (Mumbai) Ltd.

All rights reserved throughout the world.

...

As part of its efforts for OAPI, Milwaukee-based BVK/G will develop and implement the strategic marketing plan, physician referral program, professional advisory boards, and public relations efforts.

"We are very excited and honored to partner with Otsuka America Pharmaceuticals on this project," notes Bob Gessert, president of BVK/G.

"GMA will be first-in-class for the treatment of irritable bowel disease.

This new therapy will provide patients with an alternative to other current medical treatments currently on the market.

The strategic market development and physician referral process will be two key components critical to the success for the Adacolumn at launch." GMA, currently approved and on market in Japan, is an apheresis process that selectively removes the granulocytes and monocytes from the blood.

These blood cells have long been known to cause the chronic inflammation and eventual destruction of the intestinal lining.

Clinical studies have demonstrated as much as a twelve-month remission utilizing GMA with the benefit of repeating the procedure if needed.

"We are pleased to be working with BVK/G," says Rob Kemp, Manager of Commercial Development.

"Their clinical insights and strategic thinking have proven to be extremely valuable and contin...